Evidence map›Paper›PMID 39697896›Full record

ReviewInternational journal of ophthalmology2024

Development and research status of intelligent ophthalmology in China.

Di Gong, Wang-Ting Li, Xiao-Meng Li, Cheng Wan, Yong-Jin Zhou, Shu-Jun Wang, Jian-Tao Wang, Yan-Wu Xu, Shao-Chong Zhang, Wei-Hua Yang

Abstract readReview
In one paragraph

Review in International journal of ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Effective automatic classification methods via deep learning for multi-type infectious keratitis diagnosis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Di GongShenzhen Eye Hospital, Shenzhen Eye Institute, Shenzhen 518040, Guangdong Province, China.
Wang-Ting LiShenzhen Eye Hospital, Shenzhen Eye Institute, Shenzhen 518040, Guangdong Province, China.
Xiao-Meng LiDepartment of Computer Science and Engineering, Hong Kong University of Science and Technology, Hong Kong 999077, China.
Cheng WanCollege of Artificial Intelligence, Nanjing University of Aeronautics and Astronautics, Nanjing 211106, Jiangsu Province, China.
Yong-Jin ZhouShenzhen University Health Science Center School of Biomedical Engineering, Shenzhen 518061, Guangdong Province, China.
Shu-Jun WangDepartment of Biomedical Engineering, Hong Kong Polytechnical University, Hong Kong 999077, China.
Jian-Tao WangShenzhen Eye Hospital, Shenzhen Eye Institute, Shenzhen 518040, Guangdong Province, China.
Yan-Wu XuSchool of Future Technology, South China University of Technology, Guangzhou 510641, Guangdong Province, China.
Shao-Chong ZhangShenzhen Eye Hospital, Shenzhen Eye Institute, Shenzhen 518040, Guangdong Province, China.
Wei-Hua YangShenzhen Eye Hospital, Shenzhen Eye Institute, Shenzhen 518040, Guangdong Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper analyzes the current status, technological developments, academic exchange platforms, and future challenges and solutions in the field of intelligent ophthalmology (IO) in China. In terms of technology, significant progress has been made in various areas, including diabetic retinopathy, fundus image analysis, quality assessment of medical artificial intelligence products, clinical research methods, technical evaluation, and industry standards. Researchers continually enhance the safety and standardization of IO technology by formulating a series of clinical application guidelines and standards. The establishment of domestic and international academic exchange platforms provides extensive collaboration opportunities for professionals in various fields, and various academic journals serve as publication platforms for IO research. However, challenges such as technological innovation, data privacy and security, lagging regulations, and talent shortages still pose obstacles to future development. To address these issues, future efforts should focus on strengthening technological research and development, regulatory framework construction, talent cultivation, and increasing patient awareness and acceptance of new technologies. By comprehensively addressing these challenges, IO in China is poised to further lead the industry's development on a global scale, bringing more innovation and convenience to the field of ophthalmic healthcare.

Indexed as

academic exchangeimage analysisintelligent ophthalmology

Identifiers

PMID39697896
PMCPMC11589450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.